FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:765-767 September 10, 1998 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Khan, M. A. Related Article by Jick, H. Related Article by Weissman, N. J. PubMed Citation

The populations of industrialized nations are becoming steadily more overweight as a result of changes in physical activity and diet. In recent years, concern about health and appearance has led ever-increasing numbers of people to use a wide variety of diets, dietary aids, and exercise regimens to lose weight. In this regard, the prospects of successfully losing weight with the help of appetite-suppressant medication appeared to improve with the publication in 1992 of reports showing the efficacy of fenfluramine and phentermine in combination^1,2 and in 1996 with the approval by the Food and Drug Administration (FDA) of dexfenfluramine, the d-. . . [Full Text of this Article]

References

Related Letters:

Appetite-Suppressant Drugs and Valvular Heart Disease
Williamson D. F., Yanovski S. Z., Myers M. D., Moye L. A., Annegers J. F., Paoletti C. F., Shapiro S., Khan M. A., St. Peter J. V., Herzog C. A., Jick H., Weissman N. J., Gottdiener J. S., Gwynne J. T., Devereux R. B., Cannistra L. B., Cannistra A. J.
Extract | Full Text  
N Engl J Med 1999; 340:476-480, Feb 11, 1999. Correspondence

This article has been cited by other articles:

• Thomsen, W. J., Grottick, A. J., Menzaghi, F., Reyes-Saldana, H., Espitia, S., Yuskin, D., Whelan, K., Martin, M., Morgan, M., Chen, W., Al-Shamma, H., Smith, B., Chalmers, D., Behan, D. (2008). Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization. J. Pharmacol. Exp. Ther. 325: 577-587 [Abstract] [Full Text]  
• Borer, J. S., Pouleur, H., Abadie, E., Follath, F., Wittes, J., Pfeffer, M. A., Pitt, B., Zannad, F. (2007). Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval. Eur Heart J 28: 1904-1909 [Abstract] [Full Text]  
• Roth, B. L. (2007). Drugs and Valvular Heart Disease. NEJM 356: 6-9 [Full Text]  
• Boulos, A., Rolain, J.-M., Raoult, D. (2004). Antibiotic Susceptibility of Tropheryma whipplei in MRC5 Cells. Antimicrob. Agents Chemother. 48: 747-752 [Abstract] [Full Text]  
• Unger, P., Nortier, J., Muniz Martinez, M.-C., Plein, D., Vandenbossche, J.-L., Vereerstraeten, P., Vanherweghem, J.-L. (2003). High prevalence of fenfluramine-related aortic regurgitation in women with end-stage renal disease secondary to Chinese herb nephropathy. Nephrol Dial Transplant 18: 906-910 [Abstract] [Full Text]  
• Penson, R. T., Castro, C. M., Seiden, M. V., Chabner, B. A., Lynch, T. J. Jr. (2001). Complementary, Alternative, Integrative, or Unconventional Medicine?. The Oncologist 6: 463-473 [Abstract] [Full Text]  
• Rothman, R. B., Baumann, M. H., Savage, J. E., Rauser, L., McBride, A., Hufeisen, S. J., Roth, B. L. (2000). Evidence for Possible Involvement of 5-HT2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications. Circulation 102: 2836-2841 [Abstract] [Full Text]  
• Tellier, P. (1999). Aminorex to Fen/Phen: An Epidemic Foretold. Circulation 100 : e146-e146 [Full Text]  
• Biswas, S. S., Donovan, C. L., Forbess, J. M., Royal, S. H., Landolfo, K. P. (1999). Valve replacement for appetite suppressant-induced valvular heart disease. Ann. Thorac. Surg. 67: 1819-1822 [Abstract] [Full Text]  
• Friedman, M. A., Woodcock, J., Lumpkin, M. M., Shuren, J. E., Hass, A. E., Thompson, L. J. (1999). The Safety of Newly Approved Medicines: Do Recent Market Removals Mean There Is a Problem?. JAMA 281: 1728-1734 [Abstract] [Full Text]  
• Williamson, D. F., Yanovski, S. Z., Myers, M. D., Moye, L. A., Annegers, J. F., Paoletti, C. F., Shapiro, S., Khan, M. A., St. Peter, J. V., Herzog, C. A., Jick, H., Weissman, N. J., Gottdiener, J. S., Gwynne, J. T., Devereux, R. B., Cannistra, L. B., Cannistra, A. J. (1999). Appetite-Suppressant Drugs and Valvular Heart Disease. NEJM 340: 476-480 [Full Text]  
• (1998). Appetite Suppressants and Valvular Regurgitation. Journal Watch Cardiology 1998: 10-10 [Full Text]  
• (1998). Appetite Suppressants and Valvular Regurgitation. Journal Watch Cardiology 1998: 1-1 [Full Text]